Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening (2021)
- Authors:
- USP affiliated authors: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP ; FRANCISCHINI, ISAQUE ANTONIO GALINDO - FCFRP ; SILVA, GUILHERME MARTINS DA - FFCLRP ; GOMES, SUZANE QUINTANA - FFCLRP ; BARCELOS, MARIANA PEGRUCCI - FCFRP
- Unidades: FCFRP; FFCLRP
- DOI: 10.4155/fmc-2021-0025
- Subjects: ANTIVIRAIS; MEDICAMENTO; COVID-19; BANCO DE DADOS; AVALIAÇÃO DE MEDICAMENTOS; ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA)
- Keywords: Drug repositioning; Ligand-based drug discovery; Main-protease (Mpro); Structure-based drug discovery
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 13, n. 16, p. 1353-1366, 2021
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
FEDERICO, Leonardo Bruno et al. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening. Future Medicinal Chemistry, v. 13, n. 16, p. 1353-1366, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0025. Acesso em: 01 abr. 2026. -
APA
Federico, L. B., Silva, G. M. da, Melim, L. I. da S. H., Gomes, S. Q., Barcelos, M. P., Francischini, I. A. G., & Silva, C. H. T. de P. da. (2021). Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening. Future Medicinal Chemistry, 13( 16), 1353-1366. doi:10.4155/fmc-2021-0025 -
NLM
Federico LB, Silva GM da, Melim LI da SH, Gomes SQ, Barcelos MP, Francischini IAG, Silva CHT de P da. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1353-1366.[citado 2026 abr. 01 ] Available from: https://doi.org/10.4155/fmc-2021-0025 -
Vancouver
Federico LB, Silva GM da, Melim LI da SH, Gomes SQ, Barcelos MP, Francischini IAG, Silva CHT de P da. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1353-1366.[citado 2026 abr. 01 ] Available from: https://doi.org/10.4155/fmc-2021-0025 - Potential colchicine binding site inhibitors unraveled by virtual screening, molecular dynamics and MM/PBSA
- Lead optimization in drug discovery
- Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19
- Key aspects for achieving hits by virtual screening studies
- Structural aspects of organic compounds as proteasome inhibitors addressed to several diseases
- Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran
- Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius
- Revisiting the proposition of binding pockets and bioactive poses for GSK-3β allosteric modulators addressed to neurodegenerative diseases
- Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study
- In silico methods to predict relevant toxicological endpoints of bioactive substances
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003143641.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
